Senior insider sale
Chief Financial Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$72.8K
22.18K shares
What this filing means
HASTINGS DAVID C plans to sell 22.18K shares of ARBUTUS BIOPHARMA CORP valued at approximately $72.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2025ACC: 0001447028-25-000032
Officer· Chief Financial Officer
Since Mar 2019
22.18K
Shares to sell
$72.8K
Approx. market value
22.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
2/3/2025
22.18KTotal acquired22.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2025 | Restricted Stock Unit Vesting Compensation | 22.18K | — |
| Total | 22.18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
22.18K
Market value
$72.8K
2/4/2025
Total
Units
22.18K
Value
$72.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/4/2025 | 22.18K | $72.8K | NASDAQ | Planned |
| Total | 22.18K | $72.8K | ||